Aequitas Research

Hong Jie Seow

Independent Insight Provider

IPOs and Placements coverage across Asia Pacific

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Integris Medtech Limited / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/integris-medtech-limited" target="_blank" data-smartkarma-citation="entities:45943:1" rel="noopener">Integris Medtech Limited (1234518D IN)</a> is looking to raise about US$340m in its upcoming India IPO. The deal will be run by ICICI, Axis, Citi and IIFL.</li>
<li>Integris Medtech Limited is a diversified India-based global MedTech company engaged in the development, manufacturing, and commercialization of medical devices and laboratory solutions.</li>
<li>The Lab Solutions segment provides laboratory and clinical diagnostic products across hospitals and industrial labs. The Cardiovascular segment focuses on interventional cardiology devices used treatments of coronary artery disease.</li>
</ul>



Integris Medtech Limited (1234518D IN) is looking to raise about US$340m in its upcoming India IPO. The deal will be run by ICICI, Axis, Citi and IIFL.
Integris Medtech Limited is a diversified India-based global MedTech company engaged in the development, manufacturing, and commercialization of medical devices and laboratory solutions.
The Lab Solutions segment provides laboratory and clinical diagnostic products across hospitals and industrial labs. The Cardiovascular segment focuses on interventional cardiology devices used treatments of coronary artery disease.


Integris Medtech Limited Pre-IPO Tearsheet

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Samsung Electronics / Equity Capital Markets

<ul>
<li>Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.</li>
<li>On the IPO front, there were a flurry of deal launches across Hong Kong and India.</li>
<li>On the placements front, while the week was rather quiet, we did have a look at the upcoming lockup release.</li>
</ul>


Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
On the IPO front, there were a flurry of deal launches across Hong Kong and India.
On the placements front, while the week was rather quiet, we did have a look at the upcoming lockup release.


ECM Weekly (3 November 2025)-Sany, Seres, CIG, PonyAI, WeRide, Mininglamp, Lenskart, Groww, Softcare

India

Integris Medtech Limited is a diversified India-based global MedTech company engaged in the development, manufacturing, and commercialization of medical devices and laboratory solutions. 

The Lab Solutions segment provides laboratory and clinical diagnostic products across hospitals, research centers, and industrial labs. The Cardiovascular segment focuses on interventional cardiology devices used in the treatment of coronary artery disease.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Integris Medtech Limited Pre-IPO Tearsheet

​Integris Medtech Limited plans to raise $340m in India IPO, with ICICI and others leading the deal. The company is a global MedTech firm...

Hong Jie Seow

ECM Weekly (3 November 2025)-Sany, Seres, CIG, PonyAI, WeRide, Mininglamp, Lenskart, Groww, Softcare

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

Integris Medtech Limited plans to raise $340m in India IPO, with ICICI and others leading the deal. The company is a global MedTech firm...